Sinomenine inhibits breast cancer cell invasion and migration by suppressing NF-κB activation mediated by IL-4/miR-324-5p/CUEDC2 axis

Biochemical and Biophysical Research Communications

Volumn 464, Issue 3, 2015, Pages 705-710

  Song, Lingqin ^a   Liu, Di ^a   Zhao, Yang ^a   He, Jianjun ^a   Kang, Huafeng ^a   Dai, Zhijun ^a   Wang, Xijing ^a   Zhang, Shuqun ^a   Zan, Ying ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

CUEDC2; IKK phosphorylation; Invasion and metastasis; NF B; Sinomenine

Indexed keywords

CUE DOMAIN CONTAINING 2 PROTEIN; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 4; MICRORNA; MICRORNA 324 5P; SINOMENINE; TUMOR PROTEIN; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; CARRIER PROTEIN; CUEDC2 PROTEIN, HUMAN; I KAPPA B; IL4 PROTEIN, HUMAN; MEMBRANE PROTEIN; MIRN324 MICRORNA, HUMAN; MORPHINAN DERIVATIVE;

ANIMAL CELL; ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE TARGETING; HUMAN; HUMAN CELL; INCUBATION TIME; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; BREAST NEOPLASMS; CELL MOTION; CELL PROLIFERATION; DOSE RESPONSE; DRUG EFFECTS; FEMALE; GENETICS; METABOLISM; MOLECULAR MIMICRY; NEOPLASM INVASIVENESS; PATHOLOGY; PHYTOTHERAPY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CARRIER PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; I-KAPPA B PROTEINS; INTERLEUKIN-4; MEMBRANE PROTEINS; MICRORNAS; MOLECULAR MIMICRY; MORPHINANS; NEOPLASM INVASIVENESS; NF-KAPPA B; PHYTOTHERAPY;

EID: 84938739600     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.07.004     Document Type: Article

References (37)

1. C.C. Earle, H.J. Burstein, E.P. Winer, and J.C. Weeks Quality of non-breast cancer health maintenance among elderly breast cancer survivors J. Clin. Oncol. 21 2003 1447 1451
2. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, T. Murray, and M.J. Thun Cancer statistics, 2008 CA A Cancer J. Clin. 58 2008 71 96
3. R. Siegel, J. Ma, Z. Zou, and A. Jemal Cancer statistics, 2014 CA A Cancer J. Clin. 64 2014 9 29
4. A. Jemal, R. Siegel, J. Xu, and E. Ward Cancer statistics, 2010 CA A Cancer J. Clin. 60 2010 277 300
5. R.T. Greenlee, T. Murray, S. Bolden, and P.A. Wingo Cancer statistics, 2000 CA A Cancer J. Clin. 50 2000 7 33
6. N. Li, X.L. Du, L.R. Reitzel, L. Xu, and E.M. Sturgis Impact of enhanced detection on the increase in thyroid cancer incidence in the United States: review of incidence trends by socioeconomic status within the surveillance, epidemiology, and end results registry, 1980-2008 Thyroid 23 2013 103 110
7. X.-Z. Chang, J. Yin, J. Sun, X.-H. Zhang, and X.-C. Cao A retrospective study of different local treatments in breast cancer patients with synchronous ipsilateral supraclavicular lymph node metastasis J. Cancer Res. Ther. 9 2013 158
8. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2013 CA A Cancer J. Clin. 63 2013 11 30
9. A. Livolsi, V. Busuttil, V. Imbert, R.T. Abraham, and J.F. Peyron Tyrosine phosphorylation-dependent activation of NF-κB Eur. J. Biochem. 268 2001 1508 1515
10. S. Basak, V.F.-S. Shih, and A. Hoffmann Generation and activation of multiple dimeric transcription factors within the NF-κB signaling system Mol. Cell. Biol. 28 2008 3139 3150
11. E.I. Deryugina, and J.P. Quigley Matrix metalloproteinases and tumor metastasis Cancer Metastasis Rev. 25 2006 9 34
12. B.R. Zetter Angiogenesis and tumor metastasis Annu. Rev. Med. 49 1998 407 424
13. B. Zetter Adhesion molecules in tumor metastasis Seminars in cancer Biology 1993 219 229
14. P.S. Steeg Tumor metastasis: mechanistic insights and clinical challenges Nat. Med. 12 2006 895 904
15. Y. Wu, and B. Zhou TNF-α/NF-κB/Snail pathway in cancer cell migration and invasion Br. J. Cancer 102 2010 639 644
16. D. Bhaumik, G. Scott, S. Schokrpur, C. Patil, J. Campisi, and C. Benz Expression of microRNA-146 suppresses NF-κB activity with reduction of metastatic potential in breast cancer cells Oncogene 27 2008 5643 5647
17. J. Yang, and R.A. Weinberg Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis Dev. Cell. 14 2008 818 829
18. M.A. Huber, N. Azoitei, B. Baumann, S. Grünert, A. Sommer, H. Pehamberger, N. Kraut, H. Beug, and T. Wirth NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression J. Clin. Invest. 114 2004 569 581
19. S. Basak, H. Kim, J.D. Kearns, V. Tergaonkar, E. O'Dea, S.L. Werner, C.A. Benedict, C.F. Ware, G. Ghosh, and I.M. Verma A fourth IκB protein within the NF-κB signaling module Cell 128 2007 369 381
20. G. Bonizzi, M. Bebien, D.C. Otero, K.E. Johnson-Vroom, Y. Cao, D. Vu, A.G. Jegga, B.J. Aronow, G. Ghosh, and R.C. Rickert Activation of IKKα target genes depends on recognition of specific κB binding sites by RelB: p52 dimers EMBO J. 23 2004 4202 4210
21. N.D. Perkins Integrating cell-signalling pathways with NF-κB and IKK function Nat. Rev. Mol. Cell. Biol. 8 2007 49 62
22. H.-Y. Li, H. Liu, C.-H. Wang, J.-Y. Zhang, J.-H. Man, Y.-F. Gao, P.-J. Zhang, W.-H. Li, J. Zhao, and X. Pan Deactivation of the kinase IKK by CUEDC2 through recruitment of the phosphatase PP1 Nat. Immunol. 9 2008 533 541
23. Y. Chen, S.-X. Wang, R. Mu, X. Luo, Z.-S. Liu, B. Liang, H.-L. Zhuo, X.-P. Hao, Q. Wang, and D.-F. Fang Dysregulation of the MiR-324-5p-CUEDC2 axis leads to macrophage dysfunction and is associated with colon cancer Cell. Rep. 7 6 2014 1982 1993
24. H. Zhou, Y.F. Wong, J. Wang, X. Cai, and L. Liu Sinomenine ameliorates arthritis via MMPs, TIMPs, and cytokines in rats Biochem. Biophys. Res. Commun. 376 2008 352 357
25. H. Ichikawa, Y. Nakamura, Y. Kashiwada, and B.B. Aggarwal Anticancer drugs designed by mother nature: ancient drugs but modern targets Curr. Pharm. Des. 13 2007 3400 3416
26. S.C. Gupta, C. Sundaram, S. Reuter, and B.B. Aggarwal Inhibiting NF-κB activation by small molecules as a therapeutic strategy Biochim. Biophys. Acta BBA Gene Regul. Mech. 1799 2010 775 787
27. Y. Ou, W. Li, X. Li, Z. Lin, and M. Li Sinomenine reduces invasion and migration ability in fibroblast-like synoviocytes cells co-cultured with activated human monocytic THP-1 cells by inhibiting the expression of MMP-2, MMP-9, CD147 Rheumatol. Int. 31 2011 1479 1485
28. Y.-q. Ou, L.-h. Chen, X.-j. Li, Z.-b. Lin, and W.-d. Li Sinomenine influences capacity for invasion and migration in activated human monocytic THP-1 cells by inhibiting the expression of MMP-2, MMP-9, and CD147 Acta Pharmacol. Sin. 30 2009 435 441
29. Y. Zeng, B. Gu, X. Ji, X. Ding, C. Song, and F. Wu Sinomenine, an antirheumatic alkaloid, ameliorates clinical signs of disease in the Lewis rat model of acute experimental autoimmune encephalolmyelitis Biological Pharm. Bull. 30 2007 1438 1444
30. X. He, J. Wang, Z. Guo, Q. Liu, T. Chen, X. Wang, and X. Cao Requirement for ERK activation in sinomenine-induced apoptosis of macrophages Immunol. Lett. 98 2005 91 96
31. T. Jiang, L. Zhou, W. Zhang, D. Qu, X. Xu, Y. Yang, and S. Li Effects of sinomenine on proliferation and apoptosis in human lung cancer cell line NCI-H460 in vitro Mol. Med. Rep. 3 2010 51 56
32. A. Calcabrini, J.M. García-Martínez, L. González, M.J. Tendero, M.T.A. Ortuño, P. Crateri, A. Lopez-Rivas, G. Arancia, P. González-Porqué, and J. Martín-Pérez Inhibition of proliferation and induction of apoptosis in human breast cancer cells by lauryl gallate Carcinogenesis 27 2006 1699 1712
33. L. Zhou, H. Luan, Q. Liu, T. Jiang, H. Liang, X. Dong, and H. Shang Activation of PI3K/Akt and ERK signaling pathways antagonized sinomenine-induced lung cancer cell apoptosis Mol. Med. Rep. 5 2012 1256 1260
34. Y. Zhao, J. Li, K. Yu, Y. Liu, and X. Chen Sinomenine inhibits maturation of monocyte-derived dendritic cells through blocking activation of NF-kappa B Int. Immunopharmacol. 7 2007 637 645
35. H. Rauert-Wunderlich, D. Siegmund, E. Maier, T. Giner, R.C. Bargou, H. Wajant, and T. Stühmer The IKK inhibitor Bay 11-7082 induces cell death independent from inhibition of activation of NFκB transcription factors PLoS One 8 2013 e59292
36. J. Nan, Y. Du, X. Chen, Q. Bai, Y. Wang, X. Zhang, N. Zhu, J. Zhang, J. Hou, and Q. Wang TPCA-1 is a direct dual inhibitor of STAT3 and NF-κB and regresses mutant egfr-associated human non-small cell lung cancers Mol. Cancer Ther. 13 2014 617 629
37. N.D. Perkins The diverse and complex roles of NF-κB subunits in cancer Nat. Rev. Cancer 12 2012 121 132